Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_assertion type Assertion NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_head.
- NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_provenance.
- NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_assertion evidence source_evidence_literature NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_provenance.
- NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_assertion SIO_000772 15598955 NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_provenance.
- NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_assertion wasDerivedFrom befree-20140225 NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_provenance.
- NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_assertion wasGeneratedBy ECO_0000203 NP799137.RArZTjixquXrMOzdKkgMBcjj2SHq6KU9fIR-tQtth4vtk130_provenance.